Research graph
References from Adverse events of interest following influenza vaccination, a comparison of cell culture-based with egg-based alternatives: English sentinel network annual report paper 2019/20. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
External reference
Flucelvax Tetra: a surface antigen, inactivated, influenza vaccine prepared in cell cultures
10.1136/esmoopen-2018-000481 · 2019 · External reference
Cell culture-derived influenza vaccines in the severe 2017–2018 epidemic season: a step towards improved influenza vaccine effectiveness
10.1038/s41541-018-0079-z · 2018 · External reference
The impact of candidate influenza virus and egg-based manufacture on vaccine effectiveness: literature review and expert consensus
10.1016/j.vaccine.2020.06.021 · 2020 · External reference
Relative effectiveness of cell-cultured and egg-based influenza vaccines among elderly persons in the United States, 2017–2018
10.1093/infdis/jiy716 · 2019 · External reference
A real-world study evaluating the relative vaccine effectiveness of a cell-based quadrivalent influenza vaccine compared to egg-based quadrivalent influenza vaccine in the US during the 2017–18 influenza season
10.1016/j.vaccine.2020.07.023 · 2020 · External reference
Vaccine effectiveness of cell-culture relative to egg-based inactivated influenza vaccine during the 2017-18 influenza season
10.1371/journal.pone.0229279 · 2020 · External reference
Comparing influenza vaccine effectiveness between cell-derived and egg-derived vaccines, 2017–2018 influenza season
10.1016/j.vaccine.2019.06.004 · 2019 · External reference
Relative effectiveness of influenza vaccines among the United States elderly, 2018–2019
10.1093/infdis/jiaa080 · 2020 · External reference
Comparison of vaccine effectiveness against influenza hospitalization of cell-based and egg-based influenza vaccines, 2017–2018
10.1016/j.vaccine.2019.08.024 · 2019 · External reference
Unresolved reference
External reference
Unresolved reference
2019 · External reference
RCGP research and surveillance centre: 50 years’ surveillance of influenza, infections, and respiratory conditions
10.3399/bjgp17x692645 · 2017 · External reference
Royal college of general practitioners research and surveillance centre (RCGP RSC) sentinel network: a cohort profile
10.1136/bmjopen-2016-011092 · 2016 · External reference
Emergence of a novel coronavirus (COVID-19): protocol for extending surveillance used by the royal college of general practitioners research and surveillance centre and public health England
10.2196/18606 · 2020 · External reference
Brand-specific enhanced safety surveillance of GSK's Fluarix Tetra seasonal influenza vaccine in England: 2017/2018 season
10.1080/21645515.2019.1705112 · 2020 · External reference
Unresolved reference
External reference
Ethnicity recording in primary care computerised medical record systems: an ontological approach
2016 · External reference
Unresolved reference
External reference
Adverse events of interest vary by influenza vaccine type and brand: sentinel network study of eight seasons (2010–2018)
10.1016/j.vaccine.2020.03.034 · 2020 · External reference
The methodology of self-controlled case series studies
10.1177/0962280208092342 · 2009 · External reference
Self controlled case series methods: an alternative to standard epidemiological study designs
10.1136/bmj.i4515 · 2016 · External reference
Unresolved reference
2020 · External reference
Welcome to the tidyverse
10.21105/joss.01686 · 2019 · External reference
Unresolved reference
2018 · External reference
Dates and times made easy with lubridate
10.18637/jss.v040.i03 · 2011 · External reference
Unresolved reference
2020 · External reference
Unresolved reference
2016 · External reference
Unresolved reference
2019 · External reference
Reorganisation of primary care for older adults during COVID-19: a cross-sectional database study in the UK
10.3399/bjgp20x710933 · 2020 · External reference
Comparing the incidence of common adverse events of interest following influenza vaccination in the first season adjuvanted trivalent immunisation was introduced: English sentinel network annual report paper 2018/19
2020 · External reference
Immunogenicity and safety of a cell culture-based quadrivalent influenza vaccine in adults: a Phase III, double-blind, multicenter, randomized, non-inferiority study
10.1080/21645515.2016.1182270 · 2016 · External reference
Immunogenicity and safety of a cell culture-derived inactivated quadrivalent influenza vaccine (NBP607-QIV): a randomized, double-blind, multi-center, phase III clinical trial in adults and elderly subjects
10.1080/21645515.2017.1297351 · 2017 · External reference
Unresolved reference
External reference
Is there a difference in the immune response, efficacy, effectiveness and safety of seasonal influenza vaccine in males and females? – A systematic review
10.1016/j.vaccine.2019.10.091 · 2020 · External reference
Sex differences in injection site reactions with human vaccines
10.4161/hv.8476 · 2009 · External reference
Flu vaccination by pharmacists leads to suboptimal medical records
10.1136/bmj.j5084 · 2017 · External reference
Covid-19: what do we know about “long covid”?
10.1136/bmj.m2815 · 2020 · External reference
